Ftse Mib
33.815,82
0,20%
DAX
17.951,79
0,17%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
58.365,97
0,22%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Maravai LifeSciences Holdings Inc (MRVI) Maravai LifeSciences Holdings Inc (MRVI) Notizie

Maravai LifeSciences Holdings Inc

MRVI
8,42
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:06:02
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202422:49BWTriLink BioTechnologies® et Lonza signent un contrat de..
30/4/202413:31BWTriLink BioTechnologies® and Lonza Enter into Non-exclusive..
18/4/202421:12BWTriLink BioTechnologies® annonce un nouveau site à San Diego..
18/4/202421:09BWTriLink BioTechnologies® kündigt neue Anlage in San Diego..
18/4/202413:36BWTriLink BioTechnologies® Announces New San Diego Facility..
10/4/202422:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
12/3/202421:15GLOBEMaravai LifeSciences Announces March 2024 Investor..
29/2/202423:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:08EDGAR2Form 8-K - Current report
22/2/202422:05GLOBEMaravai LifeSciences Reports Fourth Quarter and Full Year..
21/2/202414:00BWTriLink BioTechnologies® Solidifies IP Position with Awarded..
21/2/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
08/2/202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202414:00GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
19/1/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202400:15EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
16/11/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202314:15GLOBEMaravai LifeSciences Announces November 2023 Investor..
08/11/202323:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:11EDGAR2Form 8-K - Current report
07/11/202322:05GLOBEMaravai LifeSciences Reports Third Quarter 2023 Financial..
02/11/202311:47BWTriLink BioTechnologies® Expands Capabilities with Launch of..
17/10/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202314:15GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
29/9/202314:15GLOBEMaravai LifeSciences Hosts 2023 Investor R&D Day
19/9/202315:31GLOBEMaravai LifeSciences Chief Innovation Officer Kate Broderick..
05/9/202322:15GLOBEMaravai LifeSciences to Host 2023 Investor R&D Day
23/8/202314:15GLOBECygnus Technologies Receives 2023 R&D 100 Award for MockV®..
22/8/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:15GLOBEMaravai LifeSciences Announces August 2023 Investor..
08/8/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:19EDGAR2Form 8-K - Current report
07/8/202322:05GLOBEMaravai LifeSciences Reports Second Quarter 2023 Financial..
27/7/202322:11EDGAR2Form 8-K - Current report
27/7/202322:05GLOBEMaravai LifeSciences Announces Completion of Planned CEO..
24/7/202322:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
20/7/202322:08EDGAR2Form 8-K - Current report
20/7/202322:05GLOBEMaravai LifeSciences Announces Appointment of New Director..
19/7/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202314:00GLOBECongressman Scott Peters Tours Maravai’s RNA manufacturing..
24/5/202322:58BWトライリンク・バイオテクノロジーズ®が製造能力拡張を発表、mRNA製造施設が完成間近
Apertura: Min: Max:
Chiusura: 8,42

La tua Cronologia

NASDAQ
MRVI
Maravai LifeSciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network